Home › Funds › Jefferies Financial Group Inc. › CGON
Jefferies Financial Group Inc. position in CGON
CG ONCOLOGY INC · Health Care
Jefferies Financial Group Inc. reported holding 835,342 shares of CGON (CG ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$59.2M, representing 1.09% of its reported portfolio and ranking #16 among its reported holdings. Jefferies Financial Group Inc. has disclosed CGON holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Jefferies Financial Group Inc.'s CGON position evolved
Jefferies Financial Group Inc. first disclosed a stake in CGON in Q2 2026 at 769,947 shares (US$54.7M). The position peaked in Q3 2026 at 835,342 shares, worth US$59.2M. Across 2 filings, Jefferies Financial Group Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 835,342 shares valued at US$59.2M — an increase of 65,395 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 769.95K | $54.70M | New |
| Q3 2026 | 835.34K | $59.22M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CGON and 13F data
CGON (CG ONCOLOGY INC) is a Health Care company. 50 other funds we track also report a position in CGON — the largest reported positions include RTW INVESTMENTS, LP (US$605.0M), Decheng Capital LLC (US$452.7M), TCG Crossover Management, LLC (US$260.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CGON
- RTW INVESTMENTS, LP 8.51M sh · $604.96M · Q2 2026
- Decheng Capital LLC 6.37M sh · $452.71M · Q2 2026
- TCG Crossover Management, LLC 3.67M sh · $260.77M · Q2 2026
- Foresite Capital Management VI LLC 2.37M sh · $168.36M · Q2 2026
- Seven Fleet Capital Management LP 1.89M sh · $134.02M · Q2 2026
- DV Trading LLC 1.44M sh · $102.27M · Q2 2026
- Avidity Partners Management LP 1.40M sh · $99.40M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 1.13M sh · $80.39M · Q2 2026
- Foresite Capital Management V, LLC 1.08M sh · $76.67M · Q2 2026
- Logos Global Management LP 1.00M sh · $71.05M · Q2 2026
- ORBIMED ADVISORS LLC 972.80K sh · $69.12M · Q2 2026
- EcoR1 Capital, LLC 561.50K sh · $39.89M · Q2 2026
More on Jefferies Financial Group Inc.
FAQ
How long has Jefferies Financial Group Inc. held CGON?
Jefferies Financial Group Inc. has disclosed CGON holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Jefferies Financial Group Inc.'s current position in CGON?
As of Q3 2026, Jefferies Financial Group Inc. holds 835.34K shares of CGON (CG ONCOLOGY INC), valued at $59.22M, representing 1.09% of its reported portfolio and ranking #16.
Has Jefferies Financial Group Inc. been buying or selling CGON?
In the latest 13F filing (Q3 2026), Jefferies Financial Group Inc. increased its position in CGON. The position peaked in Q3 2026 at 835.34K shares.
Which other funds hold CGON?
Other major institutional holders of CGON include RTW INVESTMENTS, LP, Decheng Capital LLC, TCG Crossover Management, LLC, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.